levofloxacin has been researched along with miconazole in 9 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 2,309 | 238 | 476 |
| Protein | Taxonomy | levofloxacin (IC50) | miconazole (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
| Aromatase | Homo sapiens (human) | 0.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
| Substance-K receptor | Homo sapiens (human) | 4.839 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
| Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
| Substance-P receptor | Homo sapiens (human) | 6.813 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
| Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
| Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Cholinesterase | Equus caballus (horse) | 5.55 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Al-Taweel, SA; Al-Trawneh, SA; Cavazzoni, A; El-Abadelah, MM; Incerti, M; Vicini, P; Zahra, JA; Zani, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bahekar, SS; Jawale, CS; Karnik, KS; Pansare, DN; Pawar, CD; Sarkate, AP; Shelke, RN; Shinde, DB | 1 |
| Zhang, B | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
2 review(s) available for levofloxacin and miconazole
| Article | Year |
|---|---|
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
7 other study(ies) available for levofloxacin and miconazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Thienopyridines; Topoisomerase II Inhibitors | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis and antimicrobial evaluation of novel ethyl 2-(2-(4-substituted)acetamido)-4-subtituted-thiazole-5-carboxylate derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Bacillus subtilis; Candida albicans; Carboxylic Acids; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2016 |